In suppressing the invasion of cancer cells, siRNA-mediated PARP1 inhibition leads to a reduction in epithelial-to-mesenchymal transition (EMT) via upregulation of E-cadherin and downregulation of vimentin. The gene discussed is PARP1; the disease is cancer.